Capital Management Associates (New York)’s AbbVie ABBV Stock Holding History

Capital Management Associates (New York)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,620	Closed	-$553K	–	124
2017 Q2	$553K	Hold	7,620	–	–	0.83%	47
2017 Q1	$497K	Sell	7,620 -2,500	-25%	-$157K	0.74%	58
2016 Q4	$634K	Sell	10,120 -700	-6%	-$42.7K	0.99%	38
2016 Q3	$682K	Sell	10,820 -500	-4%	-$32.4K	1.08%	29
2016 Q2	$701K	Hold	11,320	–	–	1.19%	25
2016 Q1	$647K	Hold	11,320	–	–	1.17%	27
2015 Q4	$671K	Sell	11,320 -2,450	-18%	-$141K	0.98%	33
2015 Q3	$749K	Sell	13,770 -800	-5%	-$52.1K	1.15%	22
2015 Q2	$979K	Buy	14,570 +150	+1%	+$9.79K	1.29%	8
2015 Q1	$844K	Buy	+14,420	New	+$871K	1.12%	18

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Capital Management Associates (New York)'s ABBV Position: Q3 2017 in Review

Capital Management Associates (New York) sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 7,620 shares — an estimated $553K sold.

Capital Management Associates (New York) first reported a position in ABBV in Q1 2015 and held it in 10 quarters. The position peaked at $979K in Q2 2015. 1,798 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

Capital Management Associates (New York) reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
Capital Management Associates (New York) sold 7,620 AbbVie shares in Q3 2017, an estimated $553K.
Capital Management Associates (New York) first reported a position in AbbVie in Q1 2015 and held it in 10 quarters.
Capital Management Associates (New York)'s AbbVie position peaked at $979K in Q2 2015.
1,798 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Capital Management Associates (New York)'s 13F filing for Q3 2017, filed 6 Nov 2017.